Can a vitamin treat COVID-19-related acute kidney injury?

July 27, 2021

Researchers at UT Health San Antonio, The University of Washington at Seattle and the Icahn School of Medicine at Mount Sinai in New York have launched NIRVANA, a National Institutes of Health-funded pilot clinical study to treat acute kidney injury (AKI) in COVID-19 patients.

Hiccups relief tool

Team describes science-based hiccups intervention

July 8, 2021

Researchers from UT Health San Antonio and colleagues worldwide describe a new science-based intervention for hiccups in a research letter published in the journal JAMA Network Open.

Cancer Patient with Cap Photo

Nearly all patients with cancer respond well to COVID-19 vaccines

July 1, 2021

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.

Microscope in laboratory

UT Health San Antonio scientists continue relentless fight against COVID-19

June 28, 2021

Our biochemistry team learns more about how the coronavirus disguises itself in the body.

First-in-city proton therapy center to provide alternative to radiation treatment for cancer

June 25, 2021

UT Health San Antonio and Proton International LLC are partnering to build a proton therapy center to provide an advanced alternative to conventional radiation treatment for cancer.

UT Healthier campaign sign at the San Antonio International Airport.

Traveling in a pandemic and the resumption of international business travel

June 23, 2021

By Chris Fuglestad, MFS, Office of International Services UT Health San Antonio international business will be considered again starting July 1. International business travel plays an integral role in the university’s mission to make lives better, and for many faculty members, the coronavirus pandemic brought international collaboration to an abrupt halt. But for Gabriel de Erausquin, MD, […]